Skip to search formSkip to main contentSkip to account menu

cinaciguat

Known as: 4-(((4-Carboxybutyl)(2-(2-((4-(2-Phenylethyl)Phenyl)Methoxy)Phenyl)Ethyl)Amino)Methyl)Benzoic Acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background: Pressure unloading induces the regression of left ventricular myocardial hypertrophy (LVH). Recent findings indicate… 
2019
2019
Nitric oxide (NO)-soluble guanylate cyclase(sGC)-cGMP signalling is impaired in HF syndromes, which could predispose to vascular… 
2016
2016
OBJECTIVE To investigate the mRNA expression level of plasminogen activator inhibitor-2 (PAI-2) in peripheral blood leucocytes… 
Review
2016
Review
2016
Despite advances in the field of neonatology, hypoxemic respiratory failure (HRF) and persistent pulmonary hypertension of the… 
Highly Cited
2009
Highly Cited
2009
Background—Cinaciguat (BAY 58–2667) is the first of a new class of soluble guanylate cyclase activators in clinical development…